Sanders Warns Weight Loss Drug Could Bankrupt U.S. Health System
Las Vegas, Nevada – The debate over the affordability of weight loss drugs in the United States continues to intensify as politicians and pharmaceutical companies clash over pricing policies. Bernie Sanders, a prominent advocate for healthcare reform, has raised concerns about the potential impact of expensive drugs like Ozempic on the nation’s healthcare system. Sanders recently criticized the makers of Ozempic, Novo Nordisk, for what he described as “outrageously expensive” drug prices, urging the company …